Skip to main content
    G

    Generation Bio Co (GBIO)

    Official site

    BIOTECHNOLOGY

    $5.34
    +0.00 (+0.00%)

    Last updated: Feb 09, 2026 at 4:00 PM ET

    Generation Bio Co (GBIO) Financials: Revenue, Profit and Cash Flow

    Updated Nov 6, 2025. Financial statements from company filings, amounts in US dollars.

    Generation Bio reported revenue of $19.89M for the fiscal year ended Dec 31, 2024, up 236.9% from the year before. That year, net income was -$131.67M with a net margin of -661.9%, operating cash flow was -$88.56M and free cash flow was -$90.96M. The quarter ended Sep 30, 2025 had revenue of $1.59M and net income of -$5.52M.

    Revenue and Margins

    Over the 6 years to Dec 2024, revenue grew from $36.00K, a compound annual rate of 186.5%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2024$19.89M+236.9%100.0%-715.8%-661.9%
    Dec 2023$5.90MN/A100.0%-2346.9%-2144.5%
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Dec 2019$0-100.0%N/AN/AN/A
    Dec 2018$36.00KN/A100.0%-103594.4%-99452.8%
    Annual, fiscal years ended Dec 2018 to Dec 2024

    Income Statement

    In the fiscal year ended Dec 2024, the net loss widened from the year before. In the quarter ended Sep 2025, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue$19.89M$5.90M$0$0$0$0$36.00K
    Gross profit$19.89M$5.90M$0$0$0$0$36.00K
    Research and development$61.30M$93.62M$96.72M$85.25M$58.53M$50.13M$28.15M
    Operating income-$142.39M-$138.56M-$141.18M-$119.10M-$81.11M-$62.30M-$37.29M
    Net income-$131.67M-$126.61M-$136.64M-$119.15M-$80.52M-$61.32M-$35.80M
    EBITDAN/AN/A-$138.34M-$114.04M-$77.43M-$60.76M-$36.95M
    Fiscal years ended Dec 2018 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Revenue$1.59M$765.00K$8.72M$4.19M$7.55M$4.09M$4.06M$2.88M$2.15M$880.00K$0$0
    Gross profit$1.59M$765.00K$8.72M$4.19M$7.55M$4.09M$4.06M$2.88M$2.15M$880.00K$0-$1.35M
    Operating income-$6.71M-$22.92M-$16.61M-$23.56M-$17.88M-$23.31M-$77.63M-$38.42M-$31.36M-$33.92M-$34.87M-$34.69M
    Net income-$5.52M-$20.92M-$14.80M-$21.38M-$15.31M-$20.43M-$74.54M-$35.19M-$28.27M-$31.07M-$32.09M-$32.41M
    Last 12 quarters

    Balance Sheet

    As of Dec 2024, cash and equivalents exceeded short-term debt of $13.01M by $63.30M.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$231.20M$374.76M$376.26M$476.77M$294.15M$42.14M$83.52M
    Current assets$192.90M$272.62M$287.02M$379.19M$267.74M$18.16M$76.93M
    Cash and equivalents$76.30M$66.45M$93.17M$375.14M$62.89M$15.08M$7.30M
    Total liabilities$144.99M$171.63M$93.77M$95.03M$26.14M$25.14M$125.11M
    Short-term debt$13.01M$8.12M$7.09M$4.61M$1.39M$1.37MN/A
    Shareholder equity$86.20M$203.13M$282.49M$381.75M$268.01M-$98.59M-$41.59M
    Fiscal years ended Dec 2018 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total assets$121.90M$179.43M$201.35M$231.20M$248.78M$265.26M$285.88M$374.76M$381.49M$404.88M$431.42M$376.26M
    Total liabilities$71.34M$125.33M$128.02M$144.99M$144.34M$149.86M$153.89M$171.63M$149.58M$150.60M$152.28M$93.77M
    Cash and equivalents$21.94M$49.09M$50.89M$76.30M$21.66M$28.50M$35.53M$66.45M$93.36M$144.97M$95.65M$93.17M
    Shareholder equity$50.56M$54.10M$73.33M$86.20M$104.44M$115.41M$131.99M$203.13M$231.91M$254.29M$279.14M$282.49M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2024.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow-$88.56M-$52.74M-$102.45M-$91.82M-$70.14M-$40.35M-$28.12M
    Capital expenditures$2.40M$7.40M$8.80M$5.96M$5.52M$19.99M$3.02M
    Free cash flow-$90.96M-$60.14M-$111.25M-$97.78M-$75.66M-$60.33M-$31.14M
    Share repurchases$0$164.00K$50.00K$955.00K$3.23M$22.00KN/A
    Investing cash flow$94.53M-$9.70M-$192.51M$193.05M-$205.20M$47.98M-$69.76M
    Financing cash flow$250.00K$35.82M$12.99M$214.67M$323.10M$78.00K$100.19M
    Fiscal years ended Dec 2018 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Operating cash flow-$52.68M-$16.83M-$28.36M-$15.78M-$19.55M-$21.54M-$31.70M-$24.98M-$24.90M$24.81M-$27.68M-$23.00M
    Capital expenditures$0$459.00K$246.00K$378.00K$91.00K$14.00K$1.92M$4.58M$610.00K$1.45M$755.00K$682.00K
    Free cash flow-$52.68M-$17.29M-$28.61M-$16.16M-$19.64M-$21.55M-$33.62M-$29.56M-$25.51M$23.35M-$28.43M-$23.68M
    Last 12 quarters

    Frequently Asked Questions About GBIO

    What is Generation Bio's annual revenue?

    Generation Bio reported revenue of $19.89M for the fiscal year ended Dec 31, 2024.

    How fast is Generation Bio's revenue growing?

    Revenue was up 236.9% for the fiscal year ended Dec 31, 2024 compared with the year before.

    Is Generation Bio profitable?

    No. Generation Bio reported net income of -$131.67M for the fiscal year ended Dec 31, 2024, with a net margin of -661.9%.

    How much free cash flow does GBIO generate?

    For the fiscal year ended Dec 31, 2024, operating cash flow of -$88.56M minus capital expenditures of $2.40M produced free cash flow of -$90.96M.

    How much debt does Generation Bio have?

    The balance sheet dated Dec 31, 2024 reported short-term debt of $13.01M and cash and equivalents of $76.30M.